Active — Not RecruitingNot Applicable

Implementation of P-INPAC

Canada600 participantsStarted 2023-09-04

Plain-language summary

The framework for Pediatric Integrated Nutrition Pathway for Acute Care (P-INPAC) was developed by the Canadian Malnutrition Task Force (CMTF); however, it has not been implemented in a research setting. The framework by CMTF for Integrated Nutrition Pathway for Acute Care (INPAC) in adults was also implemented in the "More-2-Eat" project which led to development of best practices in nutritional culture of the hospitals. Therefore, we intend to undertake this feasibility project at 3-sites to train staff and evaluate the implementation of P-INPAC components as part of routine healthcare procedure.

Who can participate

Age range

30 Days – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. ≥ 30 days of age and less than18 years of age on day of assessment
. Anticipated Length of hospital stay ≥24 hours from day of assessment
. Admitted to either a general medical or surgical ward
. ≥ 30 days of age and less than 18 years of age on day of assessment
. Anticipated Length of stay ≥ 24 hours from day of assessment
. Speak English (or French at Quebec site) or have a family proxy available at the meal to provide information if first language of patient is not English (or French at Quebec site)
. Patient/ caregiver provides written consent to participate

Exclusion criteria

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Baseline nutrition risk screening using STRONGkids or PNST

Timeframe: 2-month period (phase 1)

Baseline nutrition risk screening using weight

Timeframe: 2-month period (phase 1)

Baseline nutrition risk screening using height or length

Timeframe: 2-month period (phase 1)

Baseline nutrition risk screening using head circumference

Timeframe: 2-month period (phase 1)

Determine baseline knowledge among healthcare providers using the KAP questionnaire

Timeframe: 2-month period (phase 1)

Determine changes in knowledge among healthcare providers using the KAP questionnaire

Timeframe: 4-month period (phase 3)

Determine success with training and feasibility of nutrition risk screening in hospitalized children using STRONGkids and PNST

Timeframe: 4-month period (phase 3)

Trial details

NCT IDNCT06645639

SponsorThe Hospital for Sick Children

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-09-30

View on ClinicalTrials.gov More Malnutrition, Child trials

Plain-language summary

Who can participate

Age range

30 Days – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. ≥ 30 days of age and less than18 years of age on day of assessment
. Anticipated Length of hospital stay ≥24 hours from day of assessment
. Admitted to either a general medical or surgical ward
. ≥ 30 days of age and less than 18 years of age on day of assessment
. Anticipated Length of stay ≥ 24 hours from day of assessment
. Speak English (or French at Quebec site) or have a family proxy available at the meal to provide information if first language of patient is not English (or French at Quebec site)
. Patient/ caregiver provides written consent to participate

Exclusion criteria

What they're measuring

Baseline nutrition risk screening using STRONGkids or PNST

Timeframe: 2-month period (phase 1)

Baseline nutrition risk screening using weight

Timeframe: 2-month period (phase 1)

Baseline nutrition risk screening using height or length

Timeframe: 2-month period (phase 1)

Baseline nutrition risk screening using head circumference

Timeframe: 2-month period (phase 1)

Determine baseline knowledge among healthcare providers using the KAP questionnaire

Timeframe: 2-month period (phase 1)

Determine changes in knowledge among healthcare providers using the KAP questionnaire

Timeframe: 4-month period (phase 3)

Determine success with training and feasibility of nutrition risk screening in hospitalized children using STRONGkids and PNST

Timeframe: 4-month period (phase 3)